These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17118280)

  • 1. Sleep in schizophrenia: impairments, correlates, and treatment.
    Benson KL
    Psychiatr Clin North Am; 2006 Dec; 29(4):1033-45; abstract ix-x. PubMed ID: 17118280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep in schizophrenia patients and the effects of antipsychotic drugs.
    Monti JM; Monti D
    Sleep Med Rev; 2004 Apr; 8(2):133-48. PubMed ID: 15033152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antipsychotic medications on sleep in schizophrenia.
    Krystal AD; Goforth HW; Roth T
    Int Clin Psychopharmacol; 2008 May; 23(3):150-60. PubMed ID: 18408529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep and circadian rhythm dysregulation in schizophrenia.
    Monti JM; BaHammam AS; Pandi-Perumal SR; Bromundt V; Spence DW; Cardinali DP; Brown GM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():209-16. PubMed ID: 23318689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sleep disorders in schizophrenia].
    Staedt J; Hauser M; Gudlowski Y; Stoppe G
    Fortschr Neurol Psychiatr; 2010 Feb; 78(2):70-80. PubMed ID: 20066610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of melatonin in Alzheimer's disease.
    Cardinali DP; Brusco LI; Liberczuk C; Furio AM
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of visuospatial memory is associated with decreased slow wave sleep in schizophrenia.
    Göder R; Boigs M; Braun S; Friege L; Fritzer G; Aldenhoff JB; Hinze-Selch D
    J Psychiatr Res; 2004; 38(6):591-9. PubMed ID: 15458855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sleep quality and daytime sleepiness in schizophrenia spectrum disorders during antipsychotic treatment].
    Wichniak A; Waliniowska E; Wierzbicka A; Czasak K; Musińska I; Szatkowska E; Jernajczyk W; Jarema M
    Psychiatr Pol; 2009; 43(2):193-202. PubMed ID: 19697789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sleep disturbances in schizophrenia].
    Afonso P; Viveiros V; Vinhas de Sousa T
    Acta Med Port; 2011 Dec; 24 Suppl 4():799-806. PubMed ID: 22863487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.
    Luthringer R; Staner L; Noel N; Muzet M; Gassmann-Mayer C; Talluri K; Cleton A; Eerdekens M; Battisti WP; Palumbo JM
    Int Clin Psychopharmacol; 2007 Sep; 22(5):299-308. PubMed ID: 17690599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep in Schizophrenia: Pathology and Treatment.
    Benson KL
    Sleep Med Clin; 2015 Mar; 10(1):49-55. PubMed ID: 26055673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for residual insomnia in schizophrenia.
    Baandrup L; Jennum P; Lublin H; Glenthoj B
    Acta Psychiatr Scand; 2013 Jan; 127(1):81-2. PubMed ID: 23106614
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drugs for the treatment of sleep disturbances--neuroleptics and antidepressants].
    Adler L
    Z Arztl Fortbild Qualitatssich; 2001 Jan; 95(1):27-31. PubMed ID: 11233490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric disorders associated with disturbed sleep.
    Krahn LE
    Semin Neurol; 2005 Mar; 25(1):90-6. PubMed ID: 15798941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin for insomnia in children with autism spectrum disorders.
    Andersen IM; Kaczmarska J; McGrew SG; Malow BA
    J Child Neurol; 2008 May; 23(5):482-5. PubMed ID: 18182647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
    Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
    Byerly M; Suppes T; Tran QV; Baker RA
    J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.